rethinkPeptides Search
Menu
Study breakdown

Natriuretic Peptides and Programmed Cell Death Markers Together Predict Heart Failure Outcomes

Cross SectionalModerate evidence
The takeaway

Plasma BNP correlated with soluble Fas (a cell death marker) in heart failure patients, and elevated sFas independently predicted poor prognosis, linking natriuretic peptide signaling to cardiac apoptosis.

Peptides + cell death

BNP correlated with apoptosis marker sFas, and sFas independently predicted prognosis — linking heart stress peptides to cardiac cell death

What the researchers found

Plasma BNP correlated with soluble Fas (apoptosis marker) in CHF patients, and sFas independently predicted prognosis, establishing a link between natriuretic peptide signaling and cardiac programmed cell death.

Why it matters

Heart failure involves both mechanical dysfunction and cell death. Combining peptide biomarkers (BNP) with apoptosis markers (sFas) could provide a more complete picture of disease severity and trajectory.

How the study worked

Cross-sectional study measuring BNP, ANP, N-terminal ANP, soluble Fas, and TNF-alpha in congestive heart failure patients. Correlations and prognostic analysis performed.

What this study cannot tell us

Cross-sectional design; causation uncertain. The mechanistic link between BNP and sFas is correlational. Specific sFas cutoffs for clinical use not established.

How to read the evidence

Moderate evidence from a cross-sectional study with correlation and prognostic analyses in heart failure patients.

When this study was published

Published in 2001. Multi-marker approaches combining natriuretic peptides with inflammatory and apoptotic markers continue to be developed.

The bigger picture

The future of heart failure monitoring may involve multi-marker panels that capture different disease mechanisms — hormonal activation, inflammation, and cell death — for comprehensive risk assessment.

Questions still open

  • Does BNP directly promote cardiac apoptosis?
  • Should sFas be added to routine heart failure biomarker panels?
  • Can anti-apoptotic therapies improve heart failure outcomes?

Common questions

What does it mean that BNP correlates with cell death markers?
When the heart is stressed enough to release more BNP, it's also stressed enough that heart cells start dying (apoptosis). These linked processes suggest severe heart failure involves both overwork and cell loss.
Could monitoring cell death improve treatment?
Yes. If we can detect that heart cells are dying (via sFas), we might intervene with cardioprotective therapies before too much damage occurs — adding precision to heart failure management.

Read the original research

Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.

Journal of cardiac failure, 7(4), 322-8

Citation

Tsutamoto, T; Wada, A; Maeda, K; Mabuchi, N; Hayashi, M; Tsutsui, T; Ohnishi, M; Fujii, M; Matsumoto, T; Yamamoto, T; Takayama, T; Kinoshita, M. (2001). Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.. Journal of cardiac failure, 7(4), 322-8.